A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

316

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Gastric Neoplasm
Interventions
PROCEDURE

Gastrectomy with more than D2 dissection

Gastrectomy with more than D2 dissection

DRUG

Neoadjuvant chemotherapy(TS-1+CDDP) followed by gastrectomy

Neoadjuvant chemotherapy(TS-1+CDDP) followed by gastrectomy

Trial Locations (35)

464-8681

Aichi Cancer Center Hospital, Nagoya,Chikusa-ku,Kanokoden,1-1

470-1192

Fujita Health University, Toyoake,Kutsukake-cho,Dengakugakubo,1-98

277-8577

National Cancer Center Hospital East, Kashiwa,Kashiwanoha,6-5-1

790-0007

National Hospital Organization Shikoku Cancer Center, Matsuyama,Horinouchi,13

500-8323

Gifu Municipal Hospital, Gifu,Kashima-cho,7-1

730-8518

Hiroshima City Hospital, Hiroshima,Naka-ku,Motomachi,7-33

664-8540

Itami City Hospital, Itami,Koyaike,1-100

020-8505

Iwate Medical University, Morioka,Uchimaru,19-1

890-8520

Kagoshima University,Faculty of Medicine, Kagoshima,Sakuragaoka,8-35-1

241-0815

Kanagawa Cancer Center, Yokohama,Asahi-ku,Nakao,1-1-2

602-8026

Kyoto Second Red Cross Hospital, Kamigyo-ku,Kamanza-Marutamachi,355-5

981-1293

Miyagi Cancer Center, Natori,Medeshima-Shiode,Nodayama,47-1

983-8520

National Hospital Organization, Sendai Medical Center, Sendai,Miyagino-ku,Miyagino,2-8-8

940-8653

Nagaoka Chuo General Hospital, Nagaoka,Kawasaki,2041

951-8566

Niigata Cancer Center Hospital, Niigata,Kawagishi-cho,2-15-3

959-1228

Tsubame Rosai Hospital, Tsubame,Sawatari,633

879-5593

Oita University Fuculty of Medicine, Oita,Hasama-machi,Oogaoka,1-1

540-0006

Osaka National Hospital, Osaka,Chuo-ku,Hoenzaka,2-1-14

537-8511

Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka,Higashinari-ku,Nakamichi,1-3-3

589-8511

Kinki University School of Medicine, Osaka-Sayama,Ohno-higashi,377-2

590-0064

Sakai Municipal Hospital, Sakai,Minamiyasuicho,1-1-1

569-0801

Osaka Medical College, Takatsuki,Daigakucho,2-7

560-0055

Toyonaka Municipal Hospital, Toyonaka,Shibaharacho,4-14-1

362-0806

Saitama Cancer Center, Kita-adachi,Ina,Komuro,818

359-8513

National Defense Medical College, Tokorozawa,Namiki,3-2

420-8527

Shizuoka General Hospital, Shizuoka,Aoi-ku,Kitaando,4-27-1

113-8677

Tokyo Metropolitan Komagome Hospital, Bunkyo-ku,Honkomagome,3-18-22

113-8519

Tokyo Medical and Dental University Hospital, Bunkyo-ku,Yushima,1-5-45

104-0045

National Cancer Center Hospital, Chuo-ku,Tsukiji,5-1-1

135-8550

Cancer Institute Hospital, Koto-ku,Ariake,3-10-6

162-8655

International Medical Center of Japan, Shinjuku-ku,Toyama,1-21-1

130-8575

Tokyo Metropolitan Bokutoh Hospital, Sumida-ku,Koutoubashi,4-23-15

930-8550

Toyama Prefectural Central Hospital, Toyama,nishinagae,2-2-78

641-8510

Wakayama Medical University, School of Medicine, Wakayama,Kimiidera,811-1

990-2292

Yamagata Prefectural Central Hospital, Yamagata,Aoyagi,1800

All Listed Sponsors
collaborator

Ministry of Health, Labour and Welfare, Japan

OTHER_GOV

lead

Haruhiko Fukuda

OTHER

NCT00252161 - A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer | Biotech Hunter | Biotech Hunter